Cargando…

Corrigendum: Negative Symptoms of Schizophrenia and Dopaminergic Transmission: Translational Models and Perspectives Opened by iPSC Techniques

Detalles Bibliográficos
Autores principales:	Collo, Ginetta, Mucci, Armida, Giordano, Giulia M., Merlo Pich, Emilio, Galderisi, Silvana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322975/ https://www.ncbi.nlm.nih.gov/pubmed/34335179 http://dx.doi.org/10.3389/fnins.2021.729082

Ejemplares similares

Negative Symptoms of Schizophrenia and Dopaminergic Transmission: Translational Models and Perspectives Opened by iPSC Techniques
por: Collo, Ginetta, et al.
Publicado: (2020)

Alpha6-Containing Nicotinic Acetylcholine Receptors Mediate Nicotine-Induced Structural Plasticity in Mouse and Human iPSC-Derived Dopaminergic Neurons
por: Collo, Ginetta, et al.
Publicado: (2018)

A human translational model based on neuroplasticity for pharmacological agents potentially effective in Treatment-Resistant Depression: focus on dopaminergic system
por: Collo, Ginetta, et al.
Publicado: (2019)

Ketamine enhances structural plasticity in human dopaminergic neurons: possible relevance for treatment-resistant depression
por: Collo, Ginetta, et al.
Publicado: (2018)

Synergic action of L-acetylcarnitine and L-methylfolate in Mouse Models of Stress-Related Disorders and Human iPSC-Derived Dopaminergic Neurons
por: Orlando, Rosamaria, et al.
Publicado: (2022)

Ropinirole and Pramipexole Promote Structural Plasticity in Human iPSC-Derived Dopaminergic Neurons via BDNF and mTOR Signaling
por: Collo, Ginetta, et al.
Publicado: (2018)

Structural Plasticity Induced by Ketamine in Human Dopaminergic Neurons as Mechanism Relevant for Treatment-Resistant Depression
por: Collo, Ginetta, et al.
Publicado: (2019)

Gender Differences in Clinical and Psychosocial Features Among Persons With Schizophrenia: A Mini Review
por: Giordano, Giulia Maria, et al.
Publicado: (2021)

Factors influencing the outcome of integrated therapy approach in schizophrenia: A narrative review of the literature
por: Giordano, Giulia M., et al.
Publicado: (2022)

Autism Rating Scale: A New Tool for Characterizing the Schizophrenia Phenotype
por: Palumbo, Davide, et al.
Publicado: (2021)

Unveiling the Associations between EEG Indices and Cognitive Deficits in Schizophrenia-Spectrum Disorders: A Systematic Review
por: Perrottelli, Andrea, et al.
Publicado: (2022)

Abnormal bodily experiences detected by Abnormal Bodily Phenomena questionnaire are more frequent and severe in schizophrenia than in bipolar disorder with psychotic features
por: Stanghellini, Giovanni, et al.
Publicado: (2020)

F111. ELECTROPHYSIOLOGICAL CORRELATES OF AVOLITION-APATHY DOMAIN IN SCHIZOPHRENIA
por: Giordano, Giulia, et al.
Publicado: (2018)

European Psychiatric Association guidance on treatment of cognitive impairment in schizophrenia
por: Vita, Antonio, et al.
Publicado: (2022)

Structural plasticity in mesencephalic dopaminergic neurons produced by drugs of abuse: critical role of BDNF and dopamine
por: Collo, Ginetta, et al.
Publicado: (2014)

SoCIAL – training cognition in schizophrenia: a pilot study
por: Palumbo, Davide, et al.
Publicado: (2017)

Preparation and Co‐Culture of iPSC‐Derived Dopaminergic Neurons and Astrocytes
por: de Rus Jacquet, Aurelie
Publicado: (2019)

F114. DISORGANIZATION AND COGNITIVE DYSFUNCTIONS IN SCHIZOPHRENIA: A STUDY OF RESTING STATE EEG
por: Vignapiano, Ananrita, et al.
Publicado: (2018)

European Psychiatric Association guidance on assessment of cognitive impairment in schizophrenia
por: Vita, Antonio, et al.
Publicado: (2022)

Cognitive-enhancing effects of aripiprazole: a case report
por: Mucci, Armida, et al.
Publicado: (2008)

Cytokine Profiling in Human iPSC-Derived Dopaminergic Neuronal and Microglial Cultures
por: Knappe, Evelyn, et al.
Publicado: (2023)

The Efficacy, Feasibility And Acceptability Of A Remotely Accessible Use Of CIRCuiTS, A Computerized Cognitive Remediation Therapy Program For Schizophrenia: A Pilot Study
por: Palumbo, Davide, et al.
Publicado: (2019)

The Brief negative Symptom Scale (BNSS): a systematic review of measurement properties
por: Weigel, Lucia, et al.
Publicado: (2023)

Mitochondrial Dysregulation and Impaired Autophagy in iPSC-Derived Dopaminergic Neurons of Multiple System Atrophy
por: Monzio Compagnoni, Giacomo, et al.
Publicado: (2018)

Detailed Analysis of the Genetic and Epigenetic Signatures of iPSC-Derived Mesodiencephalic Dopaminergic Neurons
por: Roessler, Reinhard, et al.
Publicado: (2014)

Aberrant epigenome in iPSC‐derived dopaminergic neurons from Parkinson's disease patients
por: Fernández‐Santiago, Rubén, et al.
Publicado: (2015)

Astrocytes Attenuate Mitochondrial Dysfunctions in Human Dopaminergic Neurons Derived from iPSC
por: Du, Fang, et al.
Publicado: (2018)

Identification of ASCL1 as a determinant for human iPSC-derived dopaminergic neurons
por: Earley, Aaron M., et al.
Publicado: (2021)

Resting-State Brain Activity Dysfunctions in Schizophrenia and Their Associations with Negative Symptom Domains: An fMRI Study
por: Giordano, Giulia Maria, et al.
Publicado: (2023)

Schizophrenia and “unmet needs”: From diagnosis to care in Italy
por: Galderisi, Silvana, et al.
Publicado: (2020)

Recognition and Assessment of Cognitive Impairment in Schizophrenia
por: Mucci, A., et al.
Publicado: (2022)

Neurophysiological correlates of Avolition-apathy in schizophrenia: A resting-EEG microstates study
por: Giordano, Giulia M., et al.
Publicado: (2018)

Mitochondrial Phenotypes in Parkinson’s Diseases—A Focus on Human iPSC-Derived Dopaminergic Neurons
por: Heger, Leonie M., et al.
Publicado: (2021)

A pesticide and iPSC dopaminergic neuron screen identifies and classifies Parkinson-relevant pesticides
por: Paul, Kimberly C., et al.
Publicado: (2023)

Investigating the Relationships of P3b with Negative Symptoms and Neurocognition in Subjects with Chronic Schizophrenia
por: Giordano, Giulia M., et al.
Publicado: (2021)

Mechanistic and Translational Advances Using iPSC-Derived Blood Cells
por: Thom, Christopher S, et al.
Publicado: (2020)

The structure stability of negative symptoms: longitudinal network analysis of the Brief Negative Symptom Scale in people with schizophrenia
por: Rucci, Paola, et al.
Publicado: (2023)

Purification of functional human ES and iPSC-derived midbrain dopaminergic progenitors using LRTM1
por: Samata, Bumpei, et al.
Publicado: (2016)

Decreased Sirtuin Deacetylase Activity in LRRK2 G2019S iPSC-Derived Dopaminergic Neurons
por: Schwab, Andrew J., et al.
Publicado: (2017)

Correlations between Negative Symptoms and Cognitive Deficits in Individuals at First Psychotic Episode or at High Risk of Psychosis: A Systematic Review
por: Melillo, Antonio, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6ggkpqo1fqn23vbpi07ov3v0e8